{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:12:48Z","timestamp":1791961968151,"version":"4.3.4"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.28615","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T19:36:33Z","timestamp":1633894593000},"page":"e2128615","source":"Crossref","is-referenced-by-count":14,"title":["Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood\u2013Derived Products Marketed as Stem Cell Therapies"],"prefix":"10.1001","volume":"4","author":[{"given":"Kathleen P.","family":"Hartnett","sequence":"first","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista M.","family":"Powell","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Rankin","sequence":"additional","affiliation":[{"name":"Florida Department of Health, Tallahassee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Gable","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice J.","family":"Kim","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Spoto","sequence":"additional","affiliation":[{"name":"Florida Department of Health, Tallahassee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Breaker","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hunter","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nychie","family":"Dotson","sequence":"additional","affiliation":[{"name":"Florida Department of Health, Tallahassee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"McAllister","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Stevens","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison Laufer","family":"Halpin","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollis","family":"Houston","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Epson","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Malarkey","sequence":"additional","affiliation":[{"name":"US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Mendoza","sequence":"additional","affiliation":[{"name":"US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorrie","family":"McNeill","sequence":"additional","affiliation":[{"name":"US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran M.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"1","key":"zoi210834r1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2217\/rme-2017-0115","article-title":"The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis.","volume":"13","author":"Knoepfler","year":"2018","journal-title":"Regen Med"},{"issue":"2","key":"zoi210834r2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.stem.2016.06.007","article-title":"Selling stem cells in the USA: assessing the direct-to-consumer industry.","volume":"19","author":"Turner","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"50","key":"zoi210834r8","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.15585\/mmwr.mm6750a5","article-title":"Notes from the field: infections after receipt of bacterially contaminated umbilical cord blood-derived stem cell products for other than hematopoietic or immunologic reconstitution\u2014United States, 2018.","volume":"67","author":"Perkins","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"zoi210834r22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMp1613723","article-title":"Clarifying stem-cell therapy\u2019s benefits and risks.","volume":"376","author":"Marks","year":"2017","journal-title":"N Engl J Med"},{"key":"zoi210834r23","author":"Liveyon","year":"2017"},{"key":"zoi210834r3","unstructured":"US Food and Drug Administration. FDA warns about stem cell therapies. Updated September 3, 2019. Accessed December 13, 2020. https:\/\/www.fda.gov\/consumers\/consumer-updates\/fda-warns-about-stem-cell-therapies"},{"key":"zoi210834r4","unstructured":"US Food and Drug Administration. Warning letters (filter to issuing office: Center for Biologics Evaluation and Research, letter issue date since March 2020). Updated March 9, 2021. Accessed March 11, 2021. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/compliance-actions-and-activities\/warning-letters"},{"key":"zoi210834r5","unstructured":"US Food and Drug Administration. Enforcement Actions, CBER: BIMO\/team biologics\/internet surveillance\/other. Updated February 22, 2021. Accessed March 11, 2021. https:\/\/www.fda.gov\/vaccines-blood-biologics\/enforcement-actions-cber\/bimoteam-biologicsinternet-surveillanceother"},{"key":"zoi210834r6","unstructured":"US Food and Drug Administration. Approved cellular and gene therapy products. Updated July 24, 2020. Accessed December 13, 2020. https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/approved-cellular-and-gene-therapy-products"},{"key":"zoi210834r7","unstructured":"US Food and Drug Administration. Cord blood: what you need to know. Updated July 30, 2014. Accessed December 31, 2020. https:\/\/www.fda.gov\/consumers\/consumer-updates\/cord-blood-what-you-need-know"},{"key":"zoi210834r9","unstructured":"US Food and Drug Administration. Liveyon, LLC issues a voluntary nationwide recall of the ReGen Series\u00ae product, Manufactured by Genetech, Inc. October 2018. Accessed May 2019. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/liveyon-llc-issues-voluntary-nationwide-recall-regen-series-r-product-manufactured-genetech-inc"},{"key":"zoi210834r10","unstructured":"Epidemic Information Exchange (Epi-X). What is Epi-X? Updated April 4, 2018. Accessed December 13, 2020. https:\/\/emergency.cdc.gov\/epix\/index.asp"},{"key":"zoi210834r11","unstructured":"US Food and Drug Administration. Warning letter: Genetech, Inc. MARCS-CMS 561808. November 29, 2018. Accessed December 13, 2020. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/genetech-inc-561808-11292018"},{"key":"zoi210834r12","unstructured":"Centers for Disease Control and Prevention. Stem cell and exosome products: warning about unapproved therapies. January 2019. Accessed June 2019. https:\/\/www.cdc.gov\/hai\/outbreaks\/stem-cell-products.html"},{"key":"zoi210834r13","unstructured":"US Pharmacopeia and National Formulary. USP 41-NF 36. 2016. Accessed September 1, 2021. https:\/\/online.uspnf.com\/uspnf\/document\/GUID-AC788D41-90A2-4F36-A6E7-769954A9ED09_1_en-US"},{"key":"zoi210834r14","unstructured":"US Food and Drug Administration. Warning letter: Liveyon Labs Inc. MARCS-CMS 588399. December 5, 2019. Accessed December 14, 2020. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/liveyon-labs-inc-588399-12052019"},{"key":"zoi210834r15","unstructured":"US Food and Drug Administration. Warning letter: Cord for Life, Inc. MARCS-CMS 572770. March 29, 2019. Accessed December 14, 2020. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/cord-life-inc-572770-03292019"},{"key":"zoi210834r16","unstructured":"US Food and Drug Administration. Warning letter: Stemell, Inc. MARCS-CMS 579013. August 28, 2019. Accessed December 14, 2020. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/stemell-inc-579013-08282019"},{"key":"zoi210834r17","unstructured":"The American College of Obstetricians and Gynecologists. ACOG committee opinion: umbilical cord blood banking. December 2015. Accessed July 21, 2021. https:\/\/www.acog.org\/-\/media\/project\/acog\/acogorg\/clinical\/files\/committee-opinion\/articles\/2019\/03\/umbilical-cord-blood-banking.pdf"},{"key":"zoi210834r18","unstructured":"Centers for Disease Control and Prevention. Injection safety. Updated May 2, 2012. Accessed July 21, 2021. https:\/\/www.cdc.gov\/injectionsafety\/index.html"},{"key":"zoi210834r19","unstructured":"Siegel? JD, Rhinehart? E, Jackson? M, Chiarello? L; Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Updated July 2019. Accessed July 21, 2021. https:\/\/www.cdc.gov\/infectioncontrol\/guidelines\/isolation\/index.html"},{"key":"zoi210834r20","unstructured":"California Legislative Information. SB-512. Health care practitioners: stem cell therapy. Accessed December 14, 2020. https:\/\/leginfo.legislature.ca.gov\/faces\/billNavClient.xhtml?bill_id=201720180SB512"},{"key":"zoi210834r21","unstructured":"Federation of State Medical Boards. Regenerative and stem cell therapy practices: report and recommendations of the Workgroup to Study Regenerative and Stem Cell Therapy Practices; adopted as policy by the Federation of State Medical Boards. April 2018. Accessed December 14, 2020. https:\/\/www.fsmb.org\/siteassets\/advocacy\/policies\/fsmb-stem-cell-workgroup-report.pdf"},{"key":"zoi210834r24","unstructured":"US Food and Drug Administration. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use. July 2020. Accessed July 21, 2021. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784783\/hartnett_2021_oi_210834_1632856066.32554.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T19:37:30Z","timestamp":1633894650000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28615","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]}}}